Acerca de Lat0k

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam viverra euismod odio, gravida pellentesque urna varius vitae. Sed dui lorem, adipiscing in adipiscing et, interdum nec metus. Mauris ultricies, justo eu convallis placerat, felis enim ornare nisi vitae.
This Is A Custom Message You Can Customize In Your Admin!

Essential maintenance to computer applications on Friday

eSubmissions Web User Interface (to create the delivery file) will be unavailable between 07:00 and 09:00 on Friday, 29 September 2017 However, the EMA gateway will remain available for all communities throughout and any files submitted during that time will be queued for processing when the work is complete. The Common Repository will also be [...]

Por |2023-07-29T00:31:11+00:00julio 29th, 2023|Noticias|Sin comentarios

Phasing out of extraordinary COVID-19 regulatory flexibilities

The CMDh, in line with EMA, the European Commission (EC) and the Heads of Medicines Agencies (HMA), is phasing out the extraordinary regulatory flexibilities for medicines put in place during the COVID-19 pandemic to help address regulatory and supply challenges arising from the pandemic (see also EMA/EC/HMA announcement). This follows the end of the COVID-19 [...]

Por |2023-07-25T09:00:54+00:00julio 25th, 2023|Noticias|Sin comentarios

Essential maintenance affecting eSUB Web User Interface on Friday afternoon

eSubmissions Web User Interface (to create the delivery file) will be unavailable between 15:30 and 16:00 on Friday, 1 September 2017. However, Axway gateway will be available for all communities and any files submitted during that time will be put in a queue for processing when the deployments will be completed. If you have any [...]

Por |2023-07-24T00:17:11+00:00julio 24th, 2023|Noticias|Sin comentarios

updated version of the eCTD v4.0 EU M1 Implementation Guide

An updated version of the eCTD v4.0 EU M1 Implementation Guide is available for public consultation. The commenting period has been extended to allow sufficient time for thorough review by pharmaceutical companies, vendors of eCTD building and reviewing tools and competent authorities. The new date to submit your comments is 20th of October 2017. Please [...]

Por |2023-07-21T23:58:19+00:00julio 21st, 2023|Noticias|Sin comentarios
Ir a Arriba